ALBANY MOLECULAR RESEARCH

• 72110 - Research and experimental development on biotechnology

Curia-formerly AMRI-is an end-to-end CDMO built to help pharmaceutical and biotech companies improve patients' lives... We've come a long way from our founding in 1991 as Albany Molecular Research, Inc. (AMRI). Originally known for the discovery and development of the active pharmaceutical ingredient (API) in Allegra, we've built a strong foundation over the past three decades. Now known as Curia, we're always evolving to add a wide array of new capabilities and developing a comprehensive suite of solutions capable of serving customers across the drug development spectrum.

Also known as: Albany Molecular Research, Inc., CURIA (SCOTLAND) LIMITED

Previous names: ALBANY MOLECULAR RESEARCH (GLASGOW) LIMITED, APTUIT (GLASGOW) LIMITED, EVOTEC (SCOTLAND) LIMITED, PROPHARMA LIMITED

Registration numbers: SC181282 (CH)

Primary location: Albany United States